Document:

Exhibit
10.14

 

Cooperation
Agreement

 

for
the “Massive Health” Medical Technical Service Project

 

between

 

Ordos
Xinhai Yihecheng Mengzhongyi Hospital

 

and

 

Longduoduo
Health Technology Co., Ltd.

 

Party
A: Ordos Xinhai Yihecheng Mengzhongyi Hospital

 

Party
B: Longduoduo Health Technology Co., Ltd.

 

     

     

    

 

Cooperation
Agreement for the “Massive Health” Medical Technical Service Project

between
Ordos Xinhai Yihecheng Mengzhongyi Hospital and Longduoduo Health

Technology Co., Ltd.

 

Party
A: Ordos Xinhai Yihecheng Mengzhongyi Hospital

 

Legal
person: Zhang Min

 

Party
B: Longduoduo Health Technology Co., Ltd.

 

Legal
person: Zhang Liang

 

In
order to better carry out the Inner Mongolian “Massive Health” medical technical service project, both parties hereto reach
the following agreement through friendly negotiation in the principle of good faith, equality and mutual benefit.

 

I.
Details of the cooperative project

 

The
main cooperative projects between Party A and Party A are: “Immunological Ozonated Autohemotherapy”, “2000ml Immunological
Ozonated Autohemotherapy” and “Meridian-regulating and Consciousness-restoring Iatrotechnics” etc.

 

II.
Mode of cooperation

 

(I)
“Immunological Ozonated Autohemotherapy”

 

1.
Party A of the Project shall be responsible for providing the sites and qualifications for carrying out the cooperative projects and
the management of the medical quality of service project operation, medical safety, medical staff and drug consumables.

 

2.
Party B of the Project shall be responsible for the market operation for legal and standardized operation of the “Immunological
Ozonated Autohemotherapy” medical business and management of the client relationship.

 

(II)
“2000ml Immunological Ozonated Autohemotherapy”

 

1.
Party A of the Project shall be responsible for providing the sites and medical staff for carrying out the cooperative projects.

 

2.
Party B of the Project shall be responsible for providing compliant equipment and consumables, carrying out the market operation and
managing the client relationship.

 

(III)
“Meridian-regulating and Consciousness-restoring Iatrotechnics”

 

1.
Party A of the Project shall be responsible for providing the sites, equipment, consumables and medical staff for carrying out the cooperative
projects.

 

2.
Party B of the Project shall be responsible for providing the medical resources for Ordos Xinhai Yihecheng Mengzhongyi Hospital (such
expenses to be undertaken by Party B and paid per occurrence), signing the cooperative agreement with the hospital, carrying out the
market operation and managing the client relationship.

 

II.
Project cooperation period

 

The
cooperative period of both parties hereto shall be five years, from September 5, 2021 to September 4, 2026.

 

    2 

     

    

 

III.
Rights, responsibilities and obligations of Party A

 

1.
Party A shall be responsible for the procurement and quality control of the doctor resources and relevant drugs and consumables of the
Project.

 

2.
Party A shall be responsible for the equipment operation and the other medical services purchased by the client from Party A.

 

3.
Party A shall be responsible for the medical risk control during the implementation process of “Immunological Ozonated Autohemotherapy”
and the medical accidents due to the illegal operation of Party A. The compensation expenses shall be undertaken by Party A independently
and Party B shall not be liable for any compensation.

 

4.
Party A shall be obliged to assist Party B in completing the market expansion work and participating in relevant activities organized
by Party B and Party A allows Party B to use the trademark, name, image of Party A in a regulated and legal way to provide help for the
activities.

 

5.
Party A shall provide a waiting and negotiation room for Party B (In case of forces majeure such as relocation or removal of Party A,
the size of the office room provided to Party B shall be separated arranged by Party A) and such room shall be rent free within the five
years of contract period so as to facilitate the business development of this cooperative project. The expenses for water, electricity,
heat and property management during the room use period and the expenses for the existing furniture shall be undertaken by Party A.

 

6.
Party A shall provide the settlement receipt to Party B regularly.

 

7.
Party A may inquire the operating condition of the Project from time to time and Party B shall give active assistance.

 

IV.
Rights, responsibilities and obligations of Party B

 

1.
Party B shall ensure the legality of the business carried out and be responsible for the development and benefits of Party A and Party
B. In case of any contradiction and dispute in the market operation, Party B shall be responsible for settlement and Party A shall not
undertake any liability.

 

2.
Party B shall guarantee the supply of clients. Within the first six months in the first year after the contract conclusion, the number
of clients of “Immunological Ozonated Autohemotherapy” allocated to Party A shall not be less than 1200 while that in the
following six months in the first year shall not be less than 600. The number of clients in each later year shall not be less than 1200.

 

3.
Party B shall be responsible for the dispute and compensation arising out of the client’s dissatisfaction towards the treatment
result after the treatment is completed and Party A shall make full effort to assist Party B in settling the problems for the clients.

 

4.
Party A is the unique strategic cooperative partner (excluding Jiuzun Hospital) of the “massive health” project of Party
B in Erdos. Party B undertakes to develop Party A into the headquarter base for expanding the national business of “Longduoduo
Massive Health”, gradually introduce in and improve other cooperative projects, invest in large-scale equipment, realize sample
exhibition and national experience base.

 

5.
Party B shall ensure to mainly promote the medical projects in cooperation with Ordos Xinhai Yihecheng Mengzhongyi Hospital.

 

    3 

     

    

 

V.
Relevant benefit distribution

 

1.
“Immunological Ozonated Autohemotherapy”: RMB 800 shall be paid to Party A for each small treatment course (5 times), i.e.
average RMB 160/time (including all covered expenses): and RMB 1600 shall be paid to Party A for each big treatment course (10 times)
(including all covered expenses); the expenses for blood test and ECG before the therapy shall be collected by Party B based on the pricing
standard of second-class hospital, while for the tested items, 90% of the test expenses shall be paid to Party A.

 

2.
“2000ml Immunological Ozonated Autohemotherapy”: Party B shall make a payment to Party A at RMB 800/person/time and for each
treatment, autologous blood transfusion shall be completed in 10 cycles, with each cycle covering 200 ml. Such therapy may be completed
in two times at most due to personal reasons of the patients and additional expenses shall be charged for any excessive part. If Party
A carries out the project independently, then Party A can share the profit at 50% of the sales price.

 

3.
“Meridian-regulating and Consciousness-restoring Iatrotechnics”: Party A shall make payment to Party A at the standard of
RMB 450/person (including the medical consumables).

 

4.
In case of any other cooperative projects, additional contract agreements will be separately signed.

 

VI.
Termination of Agreement

 

1.
The “Immunological Ozonated Autohemotherapy” sold by Party A shall be RMB 320/time (not to be less than RMB 320/time).

 

2.
The price of the “Immunological Ozonated Autohemotherapy” during the process of promotion by Party B shall not be higher
than RMB 320/time (with reasonable membership price for the clients).

 

3.
If the “Immunological Ozonated Autohemotherapy” sold by Party A is less than 320/time, Party B will automatically cancel
the cooperation agreement.

 

4.
The sales price of the “2000ml Immunological Ozonated Autohemotherapy” by Party A shall not be less than RMB 5000/time;

 

5.
The retailed price of the “Meridian-regulating and Consciousness-restoring Iatrotechnics” sold by Party A shall be RMB 1800/time;

 

If
one party of Party A and Party B propose to terminate the cooperation in advance, it shall notify the other party at least 1 month in
advance, and the cancellation agreement shall be signed upon consensus.

 

VII.
Clauses regarding breach

 

1.
Party A shall strictly perform the provisions of the above mentioned clauses, and in case of breach, it shall compensate Party B for
all actual economic losses.

 

2.
Party B shall strictly perform the provisions of the above mentioned clauses, and in case of breach, it shall compensate Party A for
all actual economic losses.

 

3.
If Party B fails to pay the expert expenses as agreed, it shall be deemed a breach and all losses of Party A caused thereby shall be
undertaken by Party B.

 

VIII.
Dispute resolution

 

1.
The Agreement shall be governed by the laws of the People’s Republic of China.

 

2.
In case of any dispute regarding the existence, validity, performance, interpretation and termination of the Agreement, both parties
hereto shall make settlement through friendly negotiation. If the negotiation fails, or if any one party objects to make negotiation,
then any party hereto may apply to the court where the hospital of Party A is located or apply to the arbitration for settlement.

 

IX.
The Agreement shall be made in four copies and come into effect from the date when Party A and Party B both give the signature. Both
parties hereto shall each keep two copies. If the Agreement needs to be modified, the supplementary agreement shall be equally effective
as the Agreement.

 

    4 

     

    

 

X.
Both parties hereto are willing to sign the Agreement without force and have read and understood the provisions of the clauses as listed
herein and agree to be bound by such provisions.

 

No
text below

 

	Seal
    of Party A: Ordos Xinhai Yihecheng Mengzhongyi Hospital	 
	Signature
    of the legal person or representative:

    

     

     

     

    

    Ordos
    Xinhai Yihecheng Mengzhongyi Hospital (seal)
	 

    

    Date:
    September 5, 2021

	Seal of
    Party B: Longduoduo Health Technology Co., Ltd.	 
	Signature
    of the legal person or representative:

      

     

     

     

    

    Special
    contract seal of Longduoduo Health Technology Co., Ltd. (seal)
	 

    

    Date:
    September 5, 2021

 

 

5Exhibit 10.1

 

THIS AMENDED AND RESTATED PROMISSORY NOTE (THIS “NOTE”)
HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED
FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES
ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED.

 

AMENDED AND RESTATED PROMISSORY NOTE

 

	Principal Amount: Up to $600,000	 	Dated as of April 14, 2022

 

This Amended and Restated Promissory Note amends, restates and supersedes
in its entirety the Promissory Note dated August 24, 2020 (as may be amended from time to time), issued by Pine Island Acquisition Corp.,
a Delaware corporation (“Maker”), to Pine Island Sponsor LLC, a Delaware limited liability company, or its registered
assigns or successors in interest (collectively, “Payee”).

 

Maker promises to pay to the order of Payee, or order, the principal
sum of Six Hundred Thousand Dollars ($600,000) or such lesser amount as shall have been advanced by Payee to Maker and shall remain unpaid
under this Note on the Maturity Date (as defined below) in lawful money of the United States of America, on the terms and conditions described
below. All payments on this Note shall be made by check or wire transfer of immediately available funds or as otherwise determined by
Maker to such account as Payee may from time to time designate by written notice in accordance with the provisions of this Note.

 

1.        Principal.
The entire unpaid principal balance of this Note shall be due and payable on the earlier of: (i) November 19, 2022 and (ii) the date on
which Maker consummates a business combination (such earlier date of (i) and (ii), the “Maturity Date”) unless accelerated
upon the occurrence of an Event of Default (as defined below). The principal balance may be prepaid at any time by Maker, at its election
and without penalty. Under no circumstances shall any individual, including but not limited to any officer, director, employee or shareholder
of Maker, be obligated personally for any obligations or liabilities of Maker hereunder.

 

2.        Drawdown Requests.
Maker and Payee agree that Maker may request, from time to time, up to Six Hundred Thousand Dollars ($600,000) in drawdowns under this
Note to be used to fund Maker’s working capital requirements. The principal of this Note may be drawn down from time to time prior
to the Maturity Date upon request from Maker to Payee (each, a “Drawdown Request”). Each Drawdown Request must state
the amount to be drawn down, and must not be an amount less than Ten Thousand Dollars ($10,000) unless agreed upon by Maker and Payee.
Payee shall fund each Drawdown Request no later than three (3) business days after receipt of a Drawdown Request; provided, however,
that the maximum amount of drawdowns outstanding under this Note at any time may not exceed Six Hundred Thousand Dollars ($600,000). No
fees, payments or other amounts shall be due to Payee in connection with, or as a result of, any Drawdown Request by Maker.

 

3.        Interest.
No interest shall accrue on the unpaid principal balance of this Note.

 

4.        Application
of Payments. All payments shall be applied first to payment in full of any costs incurred in the collection of any sum due under this
Note, including (without limitation) reasonable attorney’s fees, then to the payment in full of any late charges and finally to
the reduction of the unpaid principal balance of this Note.

 

     

     

    

 

5.        Events of Default.
The following shall constitute an event of default (“Event of Default”):

 

(a)        Failure
to Make Required Payments. Failure by Maker to pay the principal amount due pursuant to this Note on the Maturity Date.

 

(b)        Voluntary
Bankruptcy, Etc. The commencement by Maker of a voluntary case under any applicable bankruptcy, insolvency, reorganization, rehabilitation
or other similar law, or the consent by it to the appointment of or taking possession by a receiver, liquidator, assignee, trustee, custodian,
sequestrator (or other similar official) of Maker or for any substantial part of its property, or the making by it of any assignment for
the benefit of creditors, or the failure of Maker generally to pay its debts as such debts become due, or the taking of corporate action
by Maker in furtherance of any of the foregoing.

 

(c)        Involuntary
Bankruptcy, Etc. The entry of a decree or order for relief by a court having jurisdiction in the premises in respect of Maker in an
involuntary case under any applicable bankruptcy, insolvency or other similar law, or appointing a receiver, liquidator, assignee, custodian,
trustee, sequestrator (or similar official) of Maker or for any substantial part of its property, or ordering the winding-up or liquidation
of its affairs, and the continuance of any such decree or order unstayed and in effect for a period of sixty (60) consecutive days.

 

6.        Remedies. 

 

(a)        Upon
the occurrence of an Event of Default specified in Section 5(a) hereof, Payee may, by written notice to Maker, declare this Note to be
due immediately and payable, whereupon the unpaid principal amount of this Note, and all other amounts payable thereunder, shall become
immediately due and payable without presentment, demand, protest or other notice of any kind, all of which are hereby expressly waived,
anything contained herein or in the documents evidencing the same to the contrary notwithstanding.

 

(b)        Upon
the occurrence of an Event of Default specified in Sections 5(b) or 5(c), the unpaid principal balance of this Note, and all other sums
payable with regard to this Note, shall automatically and immediately become due and payable, in all cases without any action on the part
of Payee.

 

7.        Waivers.
Maker and all endorsers and guarantors of, and sureties for, this Note waive presentment for payment, demand, notice of dishonor, protest,
and notice of protest with regard to the Note, all errors, defects and imperfections in any proceedings instituted by Payee under the
terms of this Note, and all benefits that might accrue to Maker by virtue of any present or future laws exempting any property, real or
personal, or any part of the proceeds arising from any sale of any such property, from attachment, levy or sale under execution, or providing
for any stay of execution, exemption from civil process, or extension of time for payment; and Maker agrees that any real estate that
may be levied upon pursuant to a judgment obtained by virtue hereof, on any writ of execution issued hereon, may be sold upon any such
writ in whole or in part in any order desired by Payee.

 

8.        Unconditional
Liability. Maker hereby waives all notices in connection with the delivery, acceptance, performance, default, or enforcement of the
payment of this Note, and agrees that its liability shall be unconditional, without regard to the liability of any other party, and shall
not be affected in any manner by any indulgence, extension of time, renewal, waiver or modification granted or consented to by Payee,
and consents to any and all extensions of time, renewals, waivers, or modifications that may be granted by Payee with respect to the payment
or other provisions of this Note, and agrees that additional makers, endorsers, guarantors, or sureties may become parties hereto without
notice to Maker or affecting Maker’s liability hereunder.

 

     

     

    

 

9.        Notices. All
notices, statements or other documents which are required or contemplated by this Note shall be: (i) in writing and delivered
personally or sent by first class registered or certified mail, overnight courier service or facsimile or electronic transmission to
the address designated in writing by such party, (ii) by facsimile to the number most recently provided to such party or such other
address or fax number as may be designated in writing by such party or (iii) by electronic mail, to the electronic mail address most
recently provided to such party or such other electronic mail address as may be designated in writing by such party. Any notice or
other communication so transmitted shall be deemed to have been given on the day of delivery, if delivered personally, on the
business day following receipt of written confirmation, if sent by facsimile or electronic transmission, one (1) business day after
delivery to an overnight courier service or five (5) days after mailing if sent by mail.

 

10.        Construction.
THIS NOTE SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE WITH THE LAWS OF NEW YORK, WITHOUT REGARD TO CONFLICT OF LAW PROVISIONS THEREOF.

 

11.        Severability.
Any provision contained in this Note which is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective
to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or
unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction.

 

12.        Trust Waiver.
Notwithstanding anything herein to the contrary, Payee hereby waives any and all right, title, interest or claim of any kind (“Claim”)
in or to any distribution of or from Maker’s trust account containing the proceeds of Maker’s initial public offering of its
securities (the “IPO”) (including the deferred underwriting discounts and commissions) and proceeds of the sale of
Maker’s warrants issued in a private placement in connection with the consummation of the IPO, as described in greater detail in
the registration statement and prospectus filed with the Securities and Exchange Commission in connection with the IPO, and hereby agrees
not to seek recourse, reimbursement, payment or satisfaction for any Claim against the trust account for any reason whatsoever.

 

13.        Amendment;
Waiver. Any amendment hereto or waiver of any provision hereof may be made with, and only with, the written consent of Maker and Payee.

 

14.        Assignment.
No assignment or transfer of this Note or any rights or obligations hereunder may be made by any party hereto (by operation of law
or otherwise) without the prior written consent of the other party hereto and any attempted assignment without the required consent shall
be void.

 

[Signature page follows] 

 

     

     

    

 

IN WITNESS WHEREOF, Maker, intending to be legally bound hereby,
has caused this Note to be duly executed by the undersigned as of the day and year first above written.

 

	 	PINE ISLAND ACQUISITION CORP.
	 	 
	 	By:	/s/ Charles Bridge
	 	Name:	Charles Bridge
	 	Title:	Chief Financial Officer and Secretary
	 	 
	PINE ISLAND SPONSOR LLC	 
	 	 	 	 
	By:	/s/ Philip Cooper	 
	Name:	 Philip Cooper	 
	Title:	 Manager	 

 

[Signature Page to Amended and Restated Promissory
Note]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00343-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00343-of-00352.parquet"}]]